Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Imagin Medical's Enterprise Value is €9.24 Mil.
Imagin Medical's EBIT for the trailing twelve months (TTM) ended in Mar. 2023 was €-0.68 Mil. Therefore, Imagin Medical's EV-to-EBIT ratio for today is -13.59.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Imagin Medical's Enterprise Value is €9.24 Mil.
Imagin Medical's EBITDA for the trailing twelve months (TTM) ended in Mar. 2023 was €-0.59 Mil. Therefore, Imagin Medical's EV-to-EBITDA ratio for today is -15.59.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Imagin Medical's Enterprise Value is €9.24 Mil.
Imagin Medical's Revenue for the trailing twelve months (TTM) ended in Mar. 2023 was €0.00 Mil. Therefore, Imagin Medical's EV-to-Revenue ratio for today is .
Imagin Medical Enterprise Value Historical Data
The historical data trend for Imagin Medical's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Imagin Medical's Enterprise Value
For the Medical Devices subindustry, Imagin Medical's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Imagin Medical's Enterprise Value Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Imagin Medical's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Imagin Medical's Enterprise Value falls into.
Imagin Medical Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Imagin Medical's Enterprise Value for the fiscal year that ended in Sep. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Imagin Medical (FRA:DPD3) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Imagin Medical's current Enterprise Value is €9.24 Mil.
Imagin Medical's EBIT for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.68 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Imagin Medical's current Enterprise Value is €9.24 Mil.
Imagin Medical's EBITDA for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.59 Mil.
Imagin Medical's current Enterprise Value is €9.24 Mil.
Imagin Medical's Revenue for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Imagin Medical Enterprise Value Related Terms
Thank you for viewing the detailed overview of Imagin Medical's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Imagin Medical Inc is a surgical imaging company focused on developing technology to visualize cancer during minimally invasive procedures. Its initial focus is bladder cancer. Imagin's first product, the i/Blue Imaging System, is based on optics and light sensors and employs patented ultrasensitive imaging technology. The company believes the system, currently in the manufacturing stage, will significantly improve surgeon's ability to visualize and remove cancer cells. Run by a Boston-based management team, the company will work to enhance its market potential in the future by expanding its technology to multiple endoscopic procedures, such as laparoscopic and thoracic procedures, accommodating multiple contrast agents and illumination sources.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:DPD3 has been successfully added to your 